UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The emerging roles of the polycistronic miR-106b∼25 cluster in cancer – A comprehensive review

Biomedicine & pharmacotherapy, 2018-11, Vol.107, p.1183-1195

2018

Volltextzugriff (PDF)

Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift

BMC genomics, 2021-12, Vol.22 (1), p.904-15, Article 904

2021

Volltextzugriff (PDF)

miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study

Histochemistry and cell biology, 2021-03, Vol.155 (3), p.423-433

2021

Volltextzugriff (PDF)

Heterogeneity in precision oncology

Cambridge prisms. Precision medicine, 2024, Vol.2, p.e2-e2, Article e2

2024

Volltextzugriff (PDF)

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways

Endocrine, 2019-09, Vol.65 (3), p.646-655

2019

Volltextzugriff (PDF)

SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas

Cell death & disease, 2023-10, Vol.14 (10), p.667-667, Article 667

2023

Volltextzugriff (PDF)

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

Scientific reports, 2022-11, Vol.12 (1), p.19660-14, Article 19660

2022

Volltextzugriff (PDF)

CDK12/13: A Promising New Therapeutic Target in ALL

Blood, 2023-11, Vol.142 (Supplement 1), p.2266-2266

2023

Volltextzugriff (PDF)

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients

Journal of clinical medicine, 2021-06, Vol.10 (12), p.2683

2021

Volltextzugriff (PDF)

Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes

Cells (Basel, Switzerland), 2021-03, Vol.10 (4), p.749

2021

Volltextzugriff (PDF)

P044: PIM kinases support protumoral and immunosuppressive phenotype and functions of macrophages in classical Hodgkin Lymphoma

HemaSphere, 2022-10, Vol.6 (Suppl), p.20-20

2022

Volltextzugriff (PDF)

Transcriptomic Features Influencing Anti-Myeloma Drug Resistance in Human Multiple Myeloma Cell Lines

Blood, 2023-11, Vol.142 (Supplement 1), p.1943-1943

2023

Volltextzugriff (PDF)

PIM1 Point Mutations Increase Migration of Diffuse Large B-Cell Lymphoma (DLBCL) Cells

Blood, 2023-11, Vol.142 (Supplement 1), p.2772-2772

2023

Volltextzugriff (PDF)

Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample

Clinical neuropathology, 2015-09, Vol.34 (5), p.288-293

2015

Volltextzugriff (PDF)

Epigenetic and Transcriptional Consequences of PIM Kinase Activity and Inhibition in Diffuse Large B-Cell Lymphoma (DLBCL)

Blood, 2023-11, Vol.142 (Supplement 1), p.5713-5713

2023

Volltextzugriff (PDF)

PIM Kinases Regulate Super-Enhancer-Dependent Gene Expression in Diffuse Large B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.3044-3045

2022

Volltextzugriff (PDF)

MEN1703-Mediated PIM Kinases Inhibition Impairs Protumoral and Immunosuppressive Phenotype and Functions of Macrophages in Classical Hodgkin Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.6441-6442

2022

Volltextzugriff (PDF)

Immunoregulatory CD71+ Erythroid Cells (CECs) Expand in Multiple Myeloma and Impair Control of L. Monocytogenes Infection

Blood, 2022-11, Vol.140 (Supplement 1), p.12538-12539

2022

Volltextzugriff (PDF)

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

Cancer research (Chicago, Ill.), 2021-12, Vol.81 (23), p.6029-6043

2021

Volltextzugriff (PDF)

Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke’s cell morphology

Pituitary, 2017-08, Vol.20 (4), p.450-463

2017

Volltextzugriff (PDF)

Hodgkin Lymphoma Reed-Sternberg Cells Induce Immunosuppressive and Pro-Angiogenic Phenotype of Tumor-Associated Macrophages in a Paracrine Manner

Blood, 2020-11, Vol.136 (Supplement 1), p.30-30

2020

Volltextzugriff (PDF)

PIM Kinase Inhibition Decreases the Proangiogenic Properties of Multiple Myeloma Cells and Affects the Metabolic State of the Vascular Endothelium

Blood, 2020-11, Vol.136 (Supplement 1), p.16-17

2020

Volltextzugriff (PDF)

TIMP4 expression is regulated by miR‐200b‐3p in prostate cancer cells

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2017-02, Vol.125 (2), p.101-105

2017

Volltextzugriff (PDF)

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Blood, 2020-11, Vol.136 (Supplement 1), p.33-34

2020

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The emerging roles of the polycistronic miR-106b∼25 cluster in cancer – A comprehensive review

Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift

miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study

Heterogeneity in precision oncology

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways

SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

CDK12/13: A Promising New Therapeutic Target in ALL

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients

Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes

P044: PIM kinases support protumoral and immunosuppressive phenotype and functions of macrophages in classical Hodgkin Lymphoma

Transcriptomic Features Influencing Anti-Myeloma Drug Resistance in Human Multiple Myeloma Cell Lines

PIM1 Point Mutations Increase Migration of Diffuse Large B-Cell Lymphoma (DLBCL) Cells

Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample

Epigenetic and Transcriptional Consequences of PIM Kinase Activity and Inhibition in Diffuse Large B-Cell Lymphoma (DLBCL)

PIM Kinases Regulate Super-Enhancer-Dependent Gene Expression in Diffuse Large B-Cell Lymphoma

MEN1703-Mediated PIM Kinases Inhibition Impairs Protumoral and Immunosuppressive Phenotype and Functions of Macrophages in Classical Hodgkin Lymphoma

Immunoregulatory CD71+ Erythroid Cells (CECs) Expand in Multiple Myeloma and Impair Control of L. Monocytogenes Infection

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

Super-Enhancer-Driven PIM Kinase Upregulation in Multiple Myeloma Maintains the Plasma Cell-Specific Oncogenic and Microenvironmental Circuits, and Can be Efficiently Targeted By the Pan-PIM Inhibitor MEN1703

Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke’s cell morphology

Hodgkin Lymphoma Reed-Sternberg Cells Induce Immunosuppressive and Pro-Angiogenic Phenotype of Tumor-Associated Macrophages in a Paracrine Manner

PIM Kinase Inhibition Decreases the Proangiogenic Properties of Multiple Myeloma Cells and Affects the Metabolic State of the Vascular Endothelium

TIMP4 expression is regulated by miR‐200b‐3p in prostate cancer cells

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Suchergebnisse filtern